Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population

Journal of Pharmaceutical Sciences

Volumn 93, Issue 12, 2004, Pages 2920-2926

  Kawasaki, Yuki ^a   Kato, Yukio ^a   Sai, Yoshimichi ^a   Tsuji, Akira ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Excretion; Membrane transport; Organic cation transporters; Renal excretion; Single nucleotide polymorphism (SNP)

Indexed keywords

CATION; GLUTAMIC ACID; GLYCINE; ORGANIC CATION TRANSPORTER; TETRYLAMMONIUM; THREONINE;

ADSORPTION KINETICS; ALLELIC EXCLUSION; AMINO ACID SUBSTITUTION; ARTICLE; BONE MARROW; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG UPTAKE; EXON; FETUS LIVER; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; JAPAN; KIDNEY; MEMBRANE TRANSPORT; PH; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; TRACHEA; UBIQUITINATION; URINARY EXCRETION;

EID: 10644270827     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20190     Document Type: Article

References (22)

1. Ishikawa T, Tsuji A, Inui K, Sai Y, Anzai N, Wada M, Endou H, Sumino Y. 2004. The genetic polymorphism of drug transporters functional analysis approaches. Pharmacogenomics 5:67-99.
2. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. 2002. JSNP: A database of common gene variations in the Japanese population. Nucleic Acids Res 30:158-162.
3. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. 1997. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEES Lett 419:107-111.
4. Tamai I, Nakanishi T, Kobayashi D, China K, Kosugi Y, Nezu J, Sai Y, Tsuji A. 2004. Involvement of OCTN2 (SLC22A4) in pH-dependent transport of organic cations. Mol Pharm 1:57-66.
5. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A. 1999. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768-773.
6. Takano M, Inui K, Okano T, Saito H, Hori R. 1984. Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 773:113-124.
7. Wright SH, Wunz TM. 1987. Transport of tetraethylammonium by rabbit renal brush-border and basolateral membrane vesicles. Am J Physiol 253: F1040-1050.
8. Maeda S, Takano M, Okano T, Ohoka K, Inui K, Hori R. 1993. Transport of organic cation in renal brush-border membrane from rats with renal ischemic injury. Biochim Biophys Acta 1150:103-110.
9. Saito S, Iida A, Sekine A, Ogawa C, Kawaguchi S, Higuchi S, Nakamura Y. 2002. Catalog of 238 variations among six human genes encoding solute carriers (ASLCs) in the Japanese population. J Hum Genet 47:576-584.
10. Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T. 2002. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 302:804-813.
11. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. 1981. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879-885.
12. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. 1998. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
13. Wu X, Prasad PD, Leibach FH, Ganapathy V. 1998. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.
14. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. 1999. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492.
15. +-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778-784.
16. +-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol 279:F584-F591.
17. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A. 1999. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
18. Mayatepek E, Nezu J, Tamai I, Oku A, Katsura M, Shimane M, Tsuji A. 2000. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum Mutat 15:118.
19. Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibira S, Matsuishi T, Tsuji A. 1999. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 8:2247-2254.
20. Ohashi R, Tamai I, Inano A, Katsura M, Sai Y, Nezu J, Tsuji A. 2002. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein. J Pharmacol Exp Ther 302:1286-1294.
21. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471-475.
22. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. 2003. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341-348.